viernes, 8 de junio de 2018

#ECFS2018 - Potential CFTR Corrector PTI-801, Plus Orkambi, Seen to Treat CF Patients in Phase 1 Trial

#ECFS2018 - Potential CFTR Corrector PTI-801, Plus Orkambi, Seen to Treat CF Patients in Phase 1 Trial

Cystic Fibrosis News Today

#ECFS2018 – Potential CFTR Corrector PTI-801, Plus Orkambi, Seen to Treat CF Patients in Phase 1 Trial

No hay comentarios:

Publicar un comentario